Inquire About a Product| Product: | Dipyridamole-d20 (Major) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D4645 | ||||||||
| Synonyms: |
2,2’,2’’,2’’’-[(4,8-Di-1-piperidinyl-D20-pyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-ethanol; NSC-515776-D20; RA-8-D20, Natyl-D20; Anginal-d20, Cardoxin-d20, Dipyridan-D20; Cleridium-D20, Persantine-D20; Peridamol-D20 |
||||||||
| Pricing: |
|
||||||||
| Formula: | C24H20N8O4D20 | ||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 524.75 | ||||||||
| Structure: |
|
||||||||
| Category: | Research Compounds | ||||||||
| Literature References: |
Brown DG, Wilkerson EC, Love WE, A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. Journal of the American Academy of Dermatology, 2015, March, 72 (3): 524–34.; De Schryver ELLM, Algra A, van Gijn J., Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database of Systematic Reviews, 2007, (2): CD001820. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled inhibitor of blood clot formation. Causes dilation of blood vessels. Inhibits the phosphodiesterase enzymes that break down cAMP and cGMP. Also inhibits cellular reuptake of adenosine into platelets, red blood cells and endothelial cells. Used to treat peripheral arterial disease and coronary artery disease. Also used to prevent strokes in patients with a history of stoke. |